NCT00442780 - Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Parkinson's Disease

Interventions

DRUG

BIIB014

oral administration of BIIB014 per dose, schedule,and duration specified in protocol

DRUG

Placebo

Oral administration of placebo matched to BIIB014 dose level; placebo to follow same dosing schedule as BIIB014

Trial Locations (10)

Research Site, Ashkelon

Research Site, Petah Tikva

Research Site, Ramat Gan

Research Site, Tel Aviv

Research Site, Kielce

Research Site, Krakow

Research Site, Poznan

Research Site, Warsaw

Research Sites, Belgrade

Research Site, Belgrade